Hope is on the horizon for needle-phobic patients as Griffith University researchers have created a new influenza vaccine ...

A groundbreaking study introduces stable inhalable mRNA treatment using nanoparticles that hold up during nebulization, ...

There's also another reason experts caution against them: their tracking limitations.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved the first influenza (flu) vaccine for at‑home use. The vaccine, ...

The elites of the anti-vaccine, “medical freedom” world saw the presidential election unfold at a hotel watch party in West ...

British prosecutors accuse Thomas Kwan of posing as a nurse and injecting 72-year-old Patrick O'Hara with a dangerous ...

The company will now prepare for the first clinical trial for a room temperature-stable needleless vaccine for Respiratory Syncytial Virus (RSV). Vaxxas chief executive David Hoey said the “Vaxxas ...

While Piedra says the FluMist spray is intended for healthy children and adults, it also works for needle-shy people. “The immune response is good for both children and adults. Like all vaccines, ...